Skip to main content

Advertisement

Table 1 The demographic and clinical characteristics of the study patients

From: The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

Variable
Age(year) All cases 55.2 ± 11.9(28–75)
Gender(n, %) Male 100, 65.4
Female 53, 34.6
Etiology of cirrhosis(n, %)
  hepatitis B 100, 65.4
hepatitis C 11, 7.2
alcoholic liver disease 19, 12.4
nonalcoholic fatty liver disease 10, 6.5
autoimmune liver disease 10, 6.5
unknown causes 3, 2.0
Cirrhosis with liver cancer(n,%) Yes 19, 12.4
NO 134, 87.6
Child-Pugh class (n,%) A 96, 62.7
B 43, 28.1
C 14, 9.2
Endoscopic treatment (n,%) EVL 54, 35.3
EIS 80, 52.3
EVL + EIS 19, 12.4
Recurrence of EV (n,%) within 1 year 89, 58.2
1–3 years 54, 35.3
Mean time of recurrence (months) From eradication to recurrence 13.4